EUROPE BLOOD MARKET FORECAST 2019-2028

EUROPE BLOOD MARKET FORECAST 2019-2028

  • August 2020 •
  • 128 pages •
  • Report ID: 5403215 •
  • Format: PDF
KEY FINDINGS
The Europe blood market is anticipated to register a CAGR of 3.82%, across the forecast years of 2019 to 2028. Factors that promote market growth comprise the upsurge in widespread blood testing and blood screening due to the coronavirus pandemic.

MARKET INSIGHTS
The Europe blood market growth is analyzed through the United Kingdom, Russia, Italy, Poland, Belgium, Germany, France, and the rest of Europe.Italy’s blood market is depicting high growth as a result of rapid blood tests conducted during the COVID-19 pandemic.

The blood system in the country is a part of the National Health Service.Thus, health care services, including blood and blood component collection, testing, processing, storage, distribution, and transfusion medicine, are delivered by the Regional Health Services, within the national legislative framework.

These services define the Ministry of Health’s functions, like, coordination, legislation, and supervision.
In Belgium, the spread of the coronavirus has plummeted the country’s stocks, due to the cancellation of blood drive events and reduced mobility of would-be-donors.According to health organizations, these events are being called off to minimize the movement of workers and encouraging them to work from home.

As a result, the initiative has significantly reduced critical supplies. Thus, the demand for blood screening techniques, and the surge in preventative measures for using blood for transfusion, is projected to bolster the region’s market growth.
COMPETITVE INSIGHTS
Major companies operating in the market include, Novo Nordisk A/S, CSL Limited (CSL Behring), Baxter International Inc, Beckton, Dickinson, and Company, Immucor Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ABBOTT LABORATORIES
2. BIO-RAD LABORATORIES INC
3. CSL LIMITED (CSL BEHRING)
4. F HOFFMANN-LA ROCHE LTD
5. GRIFOLS INTERNATIONAL SA
6. HAEMONETICS CORPORATION
7. MERCK & CO INC
8. NOVO NORDISK A/S
9. BAXTER INTERNATIONAL INC
10. BECTON DICKINSON AND COMPANY
11. FRESENIUS KABI AG
12. ORTHO CLINICAL DIAGNOSTICS
13. TERUMO CORPORATION (TERUMO BCT INC)
14. IMMUCOR INC